Polycation/DNA complexes for in vivo gene delivery

R. Kircheis, E. Wagner
{"title":"Polycation/DNA complexes for in vivo gene delivery","authors":"R. Kircheis, E. Wagner","doi":"10.1163/156855800744557","DOIUrl":null,"url":null,"abstract":"A major aim of in vivo gene transfer strategies is the efficient and specific delivery of therapeutic genes into the desired target tissues. Non-viral vectors, based on naked plasmid DNA or DNA complexes with cationic lipids or polycationic polymers, are attractive gene delivery vehicles because of their ease of manipulation, stability, low cost, safety, and their high flexibility concerning the size of the delivered transgene. A variety of non-viral vectors effective for gene transfer in cell culture have been developed. However, efficient and target specific in vivo gene delivery remains a major challenge. Compared to cell culture application, in vivo gene delivery faces a variety of additional obstacles including anatomical size constraints, and an environment of interactions with biological fluids and extracellular matrix. Furthermore, unspecific interactions with non-target cells can be a major obstacle to targeted gene delivery in vivo . Physical parameters of the transfection complexes, such as particle size, charge and stability, are critical factors determining circulation time, biodistribution and transfection efficacy in vivo . Transfection complexes have to be small enough to pass physiological barriers, inert against unspecific interactions with blood components and non-target cells, but allow specific binding to the target cells. After uptake into the target cell, escape from the endosomal compartment and nuclear uptake of the DNA are critical steps for efficient transfection. The present review focuses on the use of various polycation/DNA-based transfection systems for in vivo gene delivery.","PeriodicalId":93646,"journal":{"name":"Gene therapy and regulation","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2000-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1163/156855800744557","citationCount":"30","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gene therapy and regulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1163/156855800744557","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 30

Abstract

A major aim of in vivo gene transfer strategies is the efficient and specific delivery of therapeutic genes into the desired target tissues. Non-viral vectors, based on naked plasmid DNA or DNA complexes with cationic lipids or polycationic polymers, are attractive gene delivery vehicles because of their ease of manipulation, stability, low cost, safety, and their high flexibility concerning the size of the delivered transgene. A variety of non-viral vectors effective for gene transfer in cell culture have been developed. However, efficient and target specific in vivo gene delivery remains a major challenge. Compared to cell culture application, in vivo gene delivery faces a variety of additional obstacles including anatomical size constraints, and an environment of interactions with biological fluids and extracellular matrix. Furthermore, unspecific interactions with non-target cells can be a major obstacle to targeted gene delivery in vivo . Physical parameters of the transfection complexes, such as particle size, charge and stability, are critical factors determining circulation time, biodistribution and transfection efficacy in vivo . Transfection complexes have to be small enough to pass physiological barriers, inert against unspecific interactions with blood components and non-target cells, but allow specific binding to the target cells. After uptake into the target cell, escape from the endosomal compartment and nuclear uptake of the DNA are critical steps for efficient transfection. The present review focuses on the use of various polycation/DNA-based transfection systems for in vivo gene delivery.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
体内基因传递的多阳离子/DNA复合物
体内基因转移策略的一个主要目的是有效和特异性地将治疗基因传递到所需的靶组织中。基于裸质粒DNA或带有阳离子脂质或聚阳离子聚合物的DNA复合物的非病毒载体,由于其易于操作、稳定、低成本、安全以及在传递转基因的大小方面具有高度的灵活性,是有吸引力的基因传递载体。在细胞培养中,各种有效的基因转移的非病毒载体已经被开发出来。然而,高效和靶向特异性的体内基因传递仍然是一个主要的挑战。与细胞培养应用相比,体内基因传递面临各种额外的障碍,包括解剖尺寸限制,以及与生物流体和细胞外基质相互作用的环境。此外,与非靶细胞的非特异性相互作用可能是体内靶向基因传递的主要障碍。转染复合物的物理参数,如粒径、电荷和稳定性,是决定体内循环时间、生物分布和转染效果的关键因素。转染复合物必须足够小,以通过生理屏障,对与血液成分和非靶细胞的非特异性相互作用具有惰性,但允许与靶细胞特异性结合。在进入靶细胞后,从内体室逃逸和细胞核摄取DNA是有效转染的关键步骤。目前的综述主要集中在使用各种多阳离子/ dna为基础的转染系统在体内基因传递。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
NUCLEAR REPROGRAMMING AND THE CURRENT CHALLENGES IN ADVANCING PERSONALIZED PLURIPOTENT STEM CELL-BASED THERAPIES S/MAR VECTORS — ALTERNATIVE EXPRESSION SYSTEMS FOR GENE THERAPY? MURINE PGK PROMOTER IN A LENTIVIRAL VECTOR IN CANINE LEUKOCYTE ADHESION DEFICIENCY AND IN HUMAN LAD-1 CD34+ CELLS IN NSG MICE 3D CELL BIOPRINTING FOR REGENERATIVE MEDICINE RESEARCH AND THERAPIES EDITORIAL — NOBEL PRIZE HIGHLIGHT: SOMATIC CELL REPROGRAMMING AND THE CURRENT CLINICAL GRADE CHALLENGE
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1